Nucleo(s)tide analogue withdrawal in chronic hepatitis B virus infection: Beyond the HBsAg loss
- PMID: 35487852
- DOI: 10.1016/j.dld.2022.04.004
Nucleo(s)tide analogue withdrawal in chronic hepatitis B virus infection: Beyond the HBsAg loss
Conflict of interest statement
Conflict of competing interest None declared.
Comment in
-
Author's reply: Nucleo(s)tide analogue withdrawal in chronic hepatitis B virus infection. Beyond the HBsAg loss.Dig Liver Dis. 2022 Sep;54(9):1283-1284. doi: 10.1016/j.dld.2022.04.020. Epub 2022 May 15. Dig Liver Dis. 2022. PMID: 35581131 No abstract available.
Comment on
-
On-therapy HBsAg kinetics can predict HBsAg loss after nucleos(t)ide analogues interruption in HBeAg-negative patients. The cup is half full and half empty.Dig Liver Dis. 2022 Aug;54(8):1044-1051. doi: 10.1016/j.dld.2021.12.017. Epub 2022 Jan 19. Dig Liver Dis. 2022. PMID: 35063365
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
